Military Medicine and Medical Research as a Source of Inspiration and Innovation to Solve National Security and Health Challenges in the 21st Century
Article Sidebar
Main Article Content
Abstract
The history of military medicine and research is rife with examples of novel treatments and new approaches to heal and cure soldiers and others impacted by war’s devastation. In the 21st century, new threats, like climate change, are combined with traditional threats, like geopolitical conflict, to create novel challenges for our strategic interests. Extreme and inaccessible environments provide heightened risks for warfighter exposure to dangerous bacteria, viruses, and fungi, as well as exposure to toxic substances and extremes of temperature, pressure, or both providing threats to performance and eroding resilience. Back home, caring for our veterans is also a healthcare priority, and the diseases of veterans increasingly overlap with the health needs of an aging society. These trends of climate change, politics, and demographics suggest performance evaluation and resilience planning and response are critical to assuring both warfighter performance and societal health. The Cleveland ecosystem, comprising several hospitals, a leading University, and one of the nation’s larger Veteran’s Health Administration systems, is ideal for incubating and understanding the response to these challenges. In this review, we explore the interconnections of collaborations between Defense agencies, particularly Air Force and Army and academic medical center-based investigators to drive responses to the national health security challenges facing the United States and the world.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Pathogens and Immunity abides by Creative Commons BY 4.0:
http://creativecommons.org/licenses/by/4.0/
This license lets others distribute, remix, tweak, and build upon your work for any lawful purpose, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. The authors maintain copyright of their materal.
*Due to a template error on our pdfs, articles published from May 20, 2016 to June 24, 2022 incorrectly state the copyright is held by Pathogens and Immunity. Copyright of all articles is held by the authors of each article as noted in the above copyright policy.
References
1. Suran M. New Federal Agency for Biomedical and Health Research. JAMA. 2022;327(20):1949-. doi: 10.1001/jama.2022.8175.
2. Yeh KB, Du E, Olinger G, Boston D. Biotechnology and Biodefense Enterprise: An Industry Perspective on Defence Acquisition. Global Security: Health, Science and Policy. 2022;7(1):37-43. doi: 10.1080/23779497.2022.2102527.
3. DeChant AK, Fening S, Haag M, Harte W, Chance MR. Optimizing biomedical discoveries as an engine of culture change in an academic medical center. J Clin Transl Sci. 2022;6(1):e19. doi: 10.1017/cts.2021.888. PubMed PMID: 35291218; PMCID: PMC8889224.
4. Reizes O, Low M, Josyula VP, Ellis J, Vince DG. New programs for translating research to patient care: Lessons learned at the NIH Center for Accelerated Innovations at Cleveland Clinic. J Clin Transl Sci. 2021;5(1):e176. doi: 10.1017/cts.2021.849. PubMed PMID: 34849252; PMCID: PMC8596069.
5. Mackenbach JP. The rise and fall of diseases: reflections on the history of population health in Europe since ca. 1700. Eur J Epidemiol. 2021;36(12):1199-205. doi: 10.1007/s10654-021-00719-7. PubMed PMID: 33611677; PMCID: PMC7896827.
6. Ockenhouse CF, Magill A, Smith D, Milhous W. History of U.S. Military Contributions to the Study of Malaria. Military Medicine. 2005;170(suppl_4):12-6. doi: 10.7205/milmed.170.4s.12.
7. Ahmad W, Aquil Z, Alam S. Historical background of wound care. Hamdan Medical Journal. 2020;13(4):189-95. doi: 10.4103/hmj.Hmj_37_20.
8. Shah JB. The History of Wound Care. The Journal of the American College of Certified Wound Specialists. 2011;3(3):65-6. doi: 10.1016/j.jcws.2012.04.002.
9. Reilly RF. Medical and surgical care during the American Civil War, 1861-1865. Proc (Bayl Univ Med Cent). 2016;29(2):138-42. doi: 10.1080/08998280.2016.11929390. PubMed PMID: 27034545; PMCID: PMC4790547.
10. Figg L, Farrell-Beck J. Amputation in the Civil War: Physical and Social Dimensions. Journal of the History of Medicine and Allied Sciences. 1993;48(4):454-75. doi: 10.1093/jhmas/48.4.454.
11. Murray CK, Hinkle MK, Yun HC. History of Infections Associated With Combat-Related Injuries. Journal of Trauma and Acute Care Surgery. 2008;64(3):S221-S31. doi: 10.1097/TA.0b013e318163c40b. PubMed PMID: 00005373-200803001-00004.
12. King B, Jatoi I. The mobile Army surgical hospital (MASH): a military and surgical legacy. J Natl Med Assoc. 2005;97(5):648-56. PubMed PMID: 15926641; PMCID: PMC2569328.
13. Blyth DM, Yun HC, Tribble DR, Murray CK. Lessons of war: Combat-related injury infections during the Vietnam War and Operation Iraqi and Enduring Freedom. J Trauma Acute Care Surg. 2015;79(4 Suppl 2):S227-35. doi: 10.1097/ta.0000000000000768. PubMed PMID: 26406435; PMCID: PMC4586048.
14. Chen Y, Chau J, Yoon J, Hladky J. Rapid, label-free pathogen identification system for multidrug-resistant bacterial wound infection detection on military members in the battlefield. PLOS ONE. 2022;17(5):e0267945. doi: 10.1371/journal.pone.0267945.
15. Gajda E, Krzowski Ł, Kowalczuk K, Pabin A, Maculewicz E. Influence of mosquito-borne biological agents on health risks among soldiers and military personnel. Annals of Agricultural and Environmental Medicine. 2023;30(1):2-8. doi: 10.26444/aaem/155003.
16. Tribble DR, Murray CK, Lloyd BA, Ganesan A, Mende K, Blyth DM, Petfield JL, McDonald J. After the Battlefield: Infectious Complications among Wounded Warriors in the Trauma Infectious Disease Outcomes Study. Military Medicine. 2019;184(Supplement_2):18-25. doi: 10.1093/milmed/usz027.
17. Casadevall A. Climate change brings the specter of new infectious diseases. The Journal of Clinical Investigation. 2020;130(2):553-5. doi: 10.1172/JCI135003.
18. Carlson CJ, Albery GF, Merow C, Trisos CH, Zipfel CM, Eskew EA, Olival KJ, Ross N, Bansal S. Climate change increases cross-species viral transmission risk. Nature. 2022;607(7919):555-62. doi: 10.1038/s41586-022-04788-w.
19. Gupta S, Rouse BT, Sarangi PP. Did Climate Change Influence the Emergence, Transmission, and Expression of the COVID-19 Pandemic? Front Med (Lausanne). 2021;8:769208. doi: 10.3389/fmed.2021.769208. PubMed PMID: 34957147; PMCID: PMC8694059.
20. Damato EG, Fillioe SJ, Margevicius SP, Mayes RS, Somogyi JE, Vannix IS, Abdollahifar A, Turner AM, Ilcus LS, Decker MJ. Increased Serum Levels of Proinflammatory Cytokines Are Accompanied by Fatigue in Military T-6A Texan II Instructor Pilots. Frontiers in Physiology. 2022;13. doi: 10.3389/fphys.2022.876750.
21. Singh S, Anshita D, Ravichandiran V. MCP-1: Function, regulation, and involvement in disease. International Immunopharmacology. 2021;101:107598. doi: 10.1016/j.intimp.2021.107598.
22. Zhang J, Chen M, Peng Y, Li S, Han D, Ren S, Qin K, Li S, Han T, Wang Y, Gao Z. Wearable biosensors for human fatigue diagnosis: A review. Bioengineering & Translational Medicine. 2023;8(1):e10318. doi: 10.1002/btm2.10318.
23. Madhurantakam S, Muthukumar S, Prasad S. Emerging Electrochemical Biosensing Trends for Rapid Diagnosis of COVID-19 Biomarkers as Point-of-Care Platforms: A Critical Review. ACS Omega. 2022;7(15):12467-73. doi: 10.1021/acsomega.2c00638.
24. Arishi WA, Alhadrami HA, Zourob M. Techniques for the Detection of Sickle Cell Disease: A Review. Micromachines. 2021;12(5):519. PubMed PMID: doi: 10.3390/mi12050519.
25. Heidt B, Siqueira WF, Eersels K, Diliën H, van Grinsven B, Fujiwara RT, Cleij TJ. Point of Care Diagnostics in Resource-Limited Settings: A Review of the Present and Future of PoC in Its Most Needed Environment. Biosensors. 2020;10(10):133. PubMed PMID: doi: 10.3390/bios10100133.
26. Jain R FE, Kiselar J, Lodowski DT, Chance MR, editor. A multipronged footprinting map validates the predicted structure of stress biomarker Neuropeptide Y (NPY) and its binding with novel peptide binders. [Conference Abstract]. Annual Symposium of The Protein Society; 2023 https://www.cell.com/biophysj/pdf/S0006-3495(22)03446-4.pdf; San Diego, California: Biophysical Journal.
27. Radwan O, Brothers MC, Coyle V, Chapleau ME, Chapleau RR, Kim SS, Ruiz ON. Electrochemical biosensor for rapid detection of fungal contamination in fuel systems. Biosensors and Bioelectronics. 2022;211:114374. doi: 10.1016/j.bios.2022.114374.
28. Kinnamon D, Ghanta R, Lin K-C, Muthukumar S, Prasad S. Portable biosensor for monitoring cortisol in low-volume perspired human sweat. Scientific Reports. 2017;7(1):13312. doi: 10.1038/s41598-017-13684-7.
29. Cho I-H, Kim DH, Park S. Electrochemical biosensors: perspective on functional nanomaterials for on-site analysis. Biomaterials Research. 2020;24(1):6. doi: 10.1186/s40824-019-0181-y.
30. Moore EE, Moore HB, Kornblith LZ, Neal MD, Hoffman M, Mutch NJ, Schöchl H, Hunt BJ, Sauaia A. Trauma-induced coagulopathy. Nature Reviews Disease Primers. 2021;7(1):30. doi: 10.1038/s41572-021-00264-3.
31. Spinella PC, Dunne J, Beilman GJ, O’Connell RJ, Borgman MA, Cap AP, Rentas F. Constant challenges and evolution of US military transfusion medicine and blood operations in combat. Transfusion. 2012;52(5):1146-53. doi: 10.1111/j.1537-2995.2012.03594.x. PubMed PMID: 22575063.
32. Stubbs JR, Homer MJ, Silverman T, Cap AP. The current state of the platelet supply in the US and proposed options to decrease the risk of critical shortages. Transfusion. 2021;61(1):303-12. doi: 10.1111/trf.16140.
33. Hickman DA, Pawlowski CL, Shevitz A, Luc NF, Kim A, Girish A, Marks J, Ganjoo S, Huang S, Niedoba E, Sekhon UDS, Sun M, Dyer M, Neal MD, Kashyap VS, Sen Gupta A. Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve ‘golden hour’ survival in a porcine model of traumatic arterial hemorrhage. Scientific Reports. 2018;8(1):3118. doi: 10.1038/s41598-018-21384-z.
34. Young-McCaughan S, Rich IM, Lindsay GC, Bertram KA. The Department of Defense Congressionally Directed Medical Research Program: innovations in the federal funding of biomedical research. Clin Cancer Res. 2002;8(4):957-62. PubMed PMID: 11948100.
35. Lidie KB, Green Parker MC, Martinelli AM, Rowe SS, Leggit JC. Making an Impact: Congressionally Directed Medical Research Programs Complement Other Sources of Biomedical Funding. Fed Pract. 2015;32(1):20-7. PubMed PMID: 30766019; PMCID: PMC6363290.
36. Liu X, Li Y, Sun X, Muftuoglu Y, Wang B, Yu T, Hu Y, Ma L, Xiang M, Guo G, You C, Gao X, Wei Y. Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system. Theranostics. 2018;8(13):3490-503. doi: 10.7150/thno.24157.
37. Wong DP, Roy NK, Zhang K, Anukanth A, Asthana A, Shirkey-Son NJ, Dunmire S, Jones BJ, Lahr WS, Webber BR, Moriarity BS, Caimi P, Parameswaran R. A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers. Nature Communications. 2022;13(1):217. doi: 10.1038/s41467-021-27853-w.
38. Kochenderfer JN, Rosenberg SA. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nature Reviews Clinical Oncology. 2013;10(5):267-76. doi: 10.1038/nrclinonc.2013.46.
39. Qiu S, Pan Y, Shi S, Omotoyosi FF, Chen K, Guo Z, Lü P. Genetic Mechanism of Leukemia Relapse Following CD19 Chimeric Antigen Receptor T Cell Therapy. Cancer Biotherapy and Radiopharmaceuticals. 2021;37(5):335-41. doi: 10.1089/cbr.2020.4630.
40. Parameswaran R, Wong D, Zhang K, Asthana A, de Lima M, Caimi PF. Ligand Based CAR T-Cell Targeting BAFF Receptors Asa Novel Therapy for B Cell Malignancies. Blood. 2020;136(Supplement 1):31-2. doi: 10.1182/blood-2020-141009.
41. Pandey P, Khan F, Qari HA, Upadhyay TK, Alkhateeb AF, Oves M. Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4. Pharmaceuticals. 2022;15(3):335. PubMed PMID: doi: 10.3390/ph15030335.
42. Szabados B, Prendergast A, Jackson-Spence F, Choy J, Powles T. Immune Checkpoint Inhibitors in Front-line Therapy for Urothelial Cancer. European Urology Oncology. 2021;4(6):943-7. doi: 10.1016/j.euo.2021.02.010.
43. Zhang M, Chun L, Sandoval V, Graor H, Myers J, Nthale J, Rauhe P, Senders Z, Choong K, Huang AY, Kim J. Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer. Oncoimmunology. 2018;7(2):e1387347. doi: 10.1080/2162402x.2017.1387347. PubMed PMID: 29308312; PMCID: PMC5749667.
44. Makielski KM, Mills LJ, Sarver AL, Henson MS, Spector LG, Naik S, Modiano JF. Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review. Veterinary Sciences. 2019;6(2):48. PubMed PMID: doi: 10.3390/vetsci6020048.
45. Mason NJ. Comparative Immunology and Immunotherapy of Canine Osteosarcoma. In: Kleinerman ES, Gorlick R, editors. Current Advances in the Science of Osteosarcoma: Research Perspectives: Tumor Biology, Organ Microenvironment, Potential New Therapeutic Targets, and Canine Models. Cham: Springer International Publishing; 2020. p. 199-221.
46. Regmi S, Pathak S, Kim JO, Yong CS, Jeong J-H. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives. European Journal of Cell Biology. 2019;98(5):151041. doi: 10.1016/j.ejcb.2019.04.002.